...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Anyone find it odd?

Yes, there is the company that jonzobot refers to. There isn't much to it yet but appears to just be raising capital and looking for somewhere to invest it. Confusing but a different name so they can do it.

NBB - RVX doesn't have the kind of deal you are referring to yet either. They have a regional license deal that might make money down the road with HL paying costs in that region and a large shareholder but nothing like a CVD or anything toward a buyout. It might come down the road but it isn't as advanced as RVX. Yes, DM has hinted at it for over a year but it has never happened.

Share
New Message
Please login to post a reply